+39.011.377717
WEBINAR - NANOSCIENCE IN CANCER IMMUNOTHERAPY
Dati principali del Corso ECM RESIDENZIALE
al 11/03/21
WEBINAR - NANOSCIENCE IN CANCER IMMUNOTHERAPY
UNITO-POLITO CONFERENCE SERIES IN CANCER
The main goal of the NCIW is to provide a challenging transdisciplinary environment where life and nano scientists can exchange their knowledge and latest findings in order to accelerate and improve the coordinated progress of oncology, drug development and delivery. The program covers topics from basic research in tumor immunology to the latest advancements in the design of complex tissue models and of nanotechnology based delivery systems in cancer immunotherapy.
SUBSCRIPTION FEE
€ 70,00 iscrizione standard
PHD Students - € 50,00
Students - € 50,00
- € 7000 iva inclusa (22%)
-
- PHD students
- Students
9 March 2021
14.30 – 14.45 – SALUTI ISTITUZIONALI
14.45 – 14.55 – Introduzione e presentazione dei lavori
OPENING LECTURE
14.55 - 15.20 - Haifa SHEN - Methodist Hospital Research Institute Houston- Houston (TX, USA)
Therapeutic Cancer NanoVaccine
A ROLE FOR NANOSCIENCE IN CANCER IMMUNOTHERAPY
Chairs: Gloria BERLIER – Valentina CAUDA
15.20 - 15.45 - Jen MORTON - Beatson Institute, CRUK Glasgow Center, Glasgow (UK)
Exploring opportunities for immunotherapy in mouse models of pancreatic cancer
15.45-16:10 - Cornelis MELIEF - Dep. of Immunohemathology and Blood Transfusion Leiden University Medical Center, Leiden, (NL)
Combination immunotherapy of Cancer involving Therapeutics vaccination
16.15 – 16.35 – N. 3 AULE VIRTUALI POSTER
16.40 - 16.50 – POSTER VINCITORE 1
16.50 - 17.15 - Anna SCHWENDEMAN - University of Michigan Ann Arbor, (USA)
HDL Nanodiscs Discovery and Application for Cancer Immunotherapy
17.15 – 17.40 - Luisa DE COLA - Laboratoire de Chimie et des Biomatériaux Supramoléculaires, Univ. Strasbourg (F)
Nanocarriers for biomolecules delivery
“JUST THE WOMAN I AM” KEYNOTE LECTURE
17:40 - 18.05 - Elisabetta DEJANA – Department of Immunology, Genetics and Pathology, Uppsala (SE)
Donne e scienza: Il cervello ha genere?
10 March 2021
TUMOR MICROENVIRONMENT AND MODELS
Chairs: Valeria CHIONO – Clara MATTU
14.30– 14,55 - David TING - Massachusetts General Hospital - Cancer Center - Boston (MA, USA)
Single Cell Technologies to Define Intratumoral Heterogeneity
14.55 - 15.20 - Gabriele BERGERS - VIB-KU Leuven Center for Cancer Biology, Leuven (B)
Creating an Immune-stimulating Tumor Microenvironment: a Vascular Perspective
15.20 - 15.45 - Kairbaan HODIVALA-DILKE - Barts Cancer Institute London, London (UK)
New routes for vascular modulation
15.45 - 16.10 - Joao MANO – Department of Chemistry - University of Aveiro, Aveiro (Portugal)
Soft biomaterials for engineering 3D cancer models
16.10 - 16.35 - Giulia ADRIANI - Singapore Immunology Network (SIgN) Agency for Science, Technology and Research. Singapore
3D microfluidic model of tumor microenvironment for pre-clinical screening of immunotherapies
16.40 – 17.00 – N. 3 AULE VIRTUALI POSTER
17.05 – 17.15 – POSTER VINCITORE 2
CELL-BASED IMMUNOTHERAPY
Chairs: Paola CAPPELLO – Marco Agostino DERIU
17.15 – 17.40 - Samuel MOK - University of Texas - MD Anderson Cancer Center, Houston (TX, USA)
Anticancer immunotherapy by MFAP5 blockade suppresses ovarian cancer progression
17.40 - 18.05 - Mariolina SALIO - MRC Human Immunology Unit, WIMM, University of Oxford, Oxford (UK)
Harnessing innate-like T cells in cancer immunotherapy
18.05 - 18.30 - Michael S. GOLDBERG - Dep. of Cancer Immunology Dana-Farber Cancer Institute, Boston, (MA, USA)
Intraoperative immunotherapy
11 March 2021
MYELOID CELLS ORCHESTRATE TUMOR RESPONSE
Chair: Federico BUSSOLINO
14.30 - 14.55 - Paola ALLAVENA - Humanitas University, Rozzano (I)
Macrophage Reprogramming using TLR-agonist-loaded Polymeric Nanocapsules for the treatment of Cancer
14.55 - 15.20 - Dmitry GABRILOVICH - The Winstar Institute, Philadelphia, (PA, USA)
Regulation of tumor microenvironment by myeloid-derived suppressor cells
15.20 – 15.30 – POSTER VINCITORE 3
15.35 – 15.55 – AULE VIRTUALI POSTER
KEYNOTE LECTURE
16.00 – 16.25 - Melody SWARTZ - Pritzker School of Molecular Engineering - University of Chicago (MI, USA)
EMERGING TECHNOLOGIES IN CANCER IMMUNOLOGY
Chairs: Luca PRIMO – Alberto PULIAFITO
16.25 - 17.00 - Massimiliano PAGANI – Istituto Nazionale Genetica Molecolare - Milan (I)
Organoid models to decipher the interplay between tumor and the immune system
17.00 – 17.25 - Giovanni CIRIELLO - Université de Lausanne, (CH)
Cancer Evolutionary Dependencies
17.25 - 17.50 - Jérome GALON - Laboratory of Integrative Cancer Immunology, Sorbonne Université, Sorbonne Paris (F)
The immune contexture in the era of cancer immunotherapy
17.50 - 18.15 - Henner FARIN - Georg-Speyer-Haus - Institute Tumor Biology and Experimental Therapy – Frankfurt (D)
Patient-derived tumor organoids to model stromal interactions and cell-based immunotherapies
IL CONGRESSO SI TERRA' IN LINGUA INGLESE E NON E' PREVISTA TRADUZIONE SIMULTANEA
La prova di apprendimento potrà essere effettuata al termine del webinar entro il 14 marzo 2021. La prova di apprendimento consisterà in un questionario composto da 45 domande a risposta multipla con 4 possibilità di risposta di cui una sola giusta. La soglia di superamento prevista è del 75%. E' prevista una doppia randomizzazione delle domande.
CONOSCENZA LINGUA INGLESE
DOCUMENTAZIONE CLINICA. PERCORSI CLINICO-ASSISTENZIALI DIAGNOSTICI E RIABILITATIVI, PROFILI DI ASSISTENZA - PROFILI DI CURA
